Drug intelligence / Profile preview

monobasic sodium phosphate + dibasic sodium phosphate

Development stage
Unknown
Lead developer
Prestige Consumer Healthcare
Modality
Small Molecules
Administration
Rectal
01

Overview

Saline laxative enema, commonly known as monobasic sodium phosphate + dibasic sodium phosphate enema, is a widely used over-the-counter (OTC) rectal osmotic laxative. It is primarily indicated for the relief of occasional constipation and for bowel cleansing prior to rectal examinations, surgery, or endoscopic procedures. The formulation contains monobasic sodium phosphate and dibasic sodium phosphate as active ingredients, which work by creating an osmotic gradient in the intestinal lumen. This gradient draws water into the bowel, softening the stool and promoting rapid evacuation, typically within 1 to 5 minutes. Well-known brand equivalents include Fleet Enema and Pedia-Lax, originally developed by C.B. Fleet Company (now a subsidiary of Prestige Consumer Healthcare). Altova Healthcare also lists this product in its pipeline as a marketed generic.

Brand names
Fleet EnemaFleet Enema ExtraPedia-Lax
Other names
Monobasic Sodium Phosphate + Dibasic Sodium Phosphate enemasaline laxative enemasodium phosphate enemasodium phosphate monobasic + sodium phosphate dibasic enemasodium phosphates enema

Beyond the preview

Go deeper on monobasic sodium phosphate + dibasic sodium phosphate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on monobasic sodium phosphate + dibasic sodium phosphate.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call